Late relapse of primary central nervous system lymphoma-Reference-Cited by-同舟云学术

Late relapse of primary central nervous system lymphoma

Published:2016-07-10 Issue:2 Volume:58 Page:475-477
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Yamanaka Ryuya,Morii Ken,Shinbo Yoshikatsu,Sano Masakazu,Homma Jumpei,Tsuchiya Naoto,Yajima Naoki,Tsukamoto Yoshihiro,Ogura Ryouske,Natsumeda Manabu,Aoki Hiroshi,Akiyama Katsuhiko,Saitoh Takafumi,Tamura Tetsuro,Hondoh Hiroaki,Kawaguchi Atsushi,Takahashi Hitoshi,Fujii Yukihiko

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428194.2016.1201570

Reference14 articles.

1. Trends in survival from primary central nervous system lymphoma, 1975-1999

2. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

3. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

4. Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

5. Results of Treatment of 112 Cases of Primary CNS Lymphoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing prognostication and treatment response evaluation in primary CNS lymphoma with 18F-FDG-PET/CT;Neuro-Oncology;2024-08-04

2. Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020;Neuro-Oncology;2024-06-25

3. Diagnostics and treatment delay in primary central nervous system lymphoma: What the neurosurgeon should know;Acta Neurochirurgica;2024-06-11

4. Immune Checkpoint Inhibitors in Hodgkin Lymphoma and Non-Hodgkin Lymphoma;Immune Checkpoint Inhibitors - New Insights and Recent Progress;2023-03-08

5. Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis;BMC Cancer;2022-03-03